Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Department of Psychiatry, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
PLoS One. 2021 Dec 3;16(12):e0260929. doi: 10.1371/journal.pone.0260929. eCollection 2021.
Previous studies have revealed that the COVID-19 pandemic can cause psychological distress such as depression and anxiety. Patients with chronic kidney disease (CKD) might be more vulnerable to psychological distress due to the COVID-19 pandemic. Its impact could be different according to dialysis modality. The aim of this study was to investigate COVID-19-related psychological stress experienced by end-stage kidney disease (ESKD) patients and identify differences in concerns about COVID-19 between hemodialysis (HD) and peritoneal dialysis (PD) patients.
This cross-sectional study included 148 dialysis patients at Soonchunhyang University Cheonan Hospital from August 2020 to September 2020. These patients responded to a questionnaire covering mental health status and COVID-19 related concerns. Symptoms of depression, anxiety, stress, and insomnia were measured using a 9-item Patient Health Questionnaire (PHQ-9), a 7-item Generalized Anxiety Disorder (GAD-7) scale, a 22-item Impact of Event Scale-Revised (IES-R), and a 7-item Insomnia severity Index (ISI), respectively. Outcomes of HD and PD patients were compared by propensity score matching analysis.
Dialysis patients reported psychological distress including symptoms of depression, anxiety, stress, and insomnia. HD patients showed higher scores for depression (p = 0.018), anxiety(p = 0.005), stress(p<0.001), and insomnia(p = 0.006) than the PD patients. After propensity score matching, HD was associated with depression(p = 0.0131), anxiety(p = 0.0143), and stress(p = 0.000415).
Dialysis patients showed psychological distress during the COVID-19 pandemic period, with HD patients having more severe symptoms than PD patients.
先前的研究表明,COVID-19 大流行可导致抑郁和焦虑等心理困扰。由于 COVID-19 大流行,慢性肾脏病(CKD)患者可能更容易受到心理困扰。其影响可能因透析方式而异。本研究旨在调查终末期肾病(ESKD)患者在 COVID-19 大流行期间经历的与 COVID-19 相关的心理压力,并确定血液透析(HD)和腹膜透析(PD)患者对 COVID-19 的担忧的差异。
本横断面研究纳入了 2020 年 8 月至 2020 年 9 月期间在顺天乡大学全州医院的 148 名透析患者。这些患者通过问卷回答了心理健康状况和与 COVID-19 相关的担忧。使用 9 项患者健康问卷(PHQ-9)、7 项广泛性焦虑症(GAD-7)量表、22 项修订后的事件影响量表(IES-R)和 7 项失眠严重指数(ISI)分别测量抑郁、焦虑、压力和失眠的症状。通过倾向评分匹配分析比较 HD 和 PD 患者的结果。
透析患者报告了包括抑郁、焦虑、压力和失眠在内的心理困扰。HD 患者的抑郁(p=0.018)、焦虑(p=0.005)、压力(p<0.001)和失眠(p=0.006)得分均高于 PD 患者。经过倾向评分匹配后,HD 与抑郁(p=0.0131)、焦虑(p=0.0143)和压力(p=0.000415)相关。
在 COVID-19 大流行期间,透析患者表现出心理困扰,HD 患者的症状比 PD 患者更严重。